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A B S T R A C T   
Bioflavonoids are the largest group of plant-derived polyphenolic compounds with diverse biological potential 
and have also been proven efficacious in the treatment of Severe Acute Respiratory Syndrome (SARS) and Middle 
East Respiratory Syndrome (MERS). The present investigation validates molecular docking, simulation, and MM- 
PBSA studies of fifteen bioactive bioflavonoids derived from plants as a plausible potential antiviral in the 
treatment of COVID-19. Molecular docking studies for 15 flavonoids on the three SARS CoV-2 proteins, non- 
structural protein-15 Endoribonuclease (NSP15), the receptor-binding domain of spike protein (RBD of S pro-
tein), and main protease (Mpro/3CLpro) were performed and selected protein-ligand complexes were subjected to 
Molecular Dynamics simulations. The molecular dynamics trajectories were subjected to free energy calculation 
by the MM-PBSA method. All flavonoids were further assessed for their effectiveness as adjuvant therapy by 
network pharmacology analysis on the target proteins. The network pharmacology analysis suggests the 
involvement of selected bioflavonoids in the modulation of multiple signaling pathways like p53, FoxO, MAPK, 
Wnt, Rap1, TNF, adipocytokine, and leukocyte transendothelial migration which plays a significant role in 
immunomodulation, minimizing the oxidative stress and inflammation. Molecular docking and molecular dy-
namics simulation studies illustrated the potential of glycyrrhizic acid, amentoflavone, and mulberroside in 
inhibiting key SARS-CoV-2 proteins and these results could be exploited further in designing future ligands from 
natural sources.   
Abbreviations: 2019-nCoV, 2019 Novel Coronavirus; CoV, Corona Virus; Å, Angstrom; COVID-19, Coronavirus Disease-2019; MD, Molecular Dynamics; MM-PBSA, 
Molecular Mechanics Poisson-Boltzmann Surface Area; NSP, Non-structural Protein; ORF, Open Reading Frame; OPLS, Optimized Potentials for Liquid Simulations; 
RBD, Receptor Binding Domain; RMSD, Root Mean Square Deviation; SARS, Severe Acute Respiratory syndrome; SARS-CoV-2, Severe Acute Respiratory syndrome 
Coronavirus-2; SDF, Structure Data File; WHO, World Health Organization. 
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1. Introduction 
During December 2019, severe acute respiratory syndrome corona-
virus 2 (SARS-CoV-2) emerged as a global pandemic originating from 
the Wuhan city of China, and still it is a major global threat due to high 
mortality and morbidity rates. The coronaviruses contain highly envel-
oped single stranded RNA with the genome size of 26–32 kilobases and 
requires the initial RNA synthesis, replication and transcription for its 
life cycle [1–3]. Two-thirds of the genome of all coronoviruses encodes 
pp1ab, a replicase polyprotein which comprises of two overlapping open 
reading frames (ORF1a and ORF1b), cleaved into 16 different 
non-structural proteins (NSPs) by viral proteases [4]. Amongst these 
NSPs, NSP-15 is ascribed with nidoviral uridylate-specific endor-
ibonuclease (NendoU) activity involving uridylate-specific cleavage of 
RNAs. NSP-15/NendoU activity is important in the innate immune re-
sponses and the viral life cycle [5]. The structural protein protruding on 
viral surface called spike (S) glycoprotein which exist as a metastable 
prefusion homotrimeric form enables the entry of 2019-nCoV into the 
host cells through structural rearrangement. The binding of the S1 
subunit of spike S glycoprotein to the angiotensin-converting enzyme 2 
(ACE2) on the host cell leads to the transition of the S2 subunit to a 
highly stable post-fusion conformation which accelerates the viral entry 
process. Hence, the drugs targeting the viral proteases, nonstructural 
proteins and structural protein that block various stages of viral life 
cycle such as the entry, replication, and proliferation may exhibit a wide 
spectrum of activity [6–9]. 
The natural compounds, especially from plant resources, remained 
the choice in the lead identification programs due to their abundance, 
safety and broad spectrum of ensuing activities. The flavonoids, bio-
flavonoids or polyphenolic compounds are a group of secondary me-
tabolites present in fruits and vegetables and are well known for their 
health benefits. Flavonoids, a group of compounds containing flavan 
nucleus or a 15-carbon skeleton with two benezene rings linked through 
pyran ring, are well studied natural compounds comprising more than 
6000 structurally well characterized molecules [10]. They are reported 
to possess health benefits in infectious, oncogenic, inflammatory and 
degenerative diseases [11–14]. It is noteworthy that flavonoids have 
been extensively studied against the plethora of viruses to overcome the 
limitations of existing therapies [15–27]. The recent in-silico studies 
have demonstrated the antiviral potential of natural compounds in 
COVID-19 [1–3,28]. 
Flavonoids have been proven to have a multidimensional therapeutic 
effect such as anti-inflammatory, antiviral, antioxidant, car-
dioprotective, and have also shown their significant role in the treat-
ment of respiratory associated problems, which are a key requirement 
for a drug to be effective against COVID-19 [1–3,28]. In the present 
Fig. 1. Binding site residues (A) SARS-CoV-2 NSP15 protein (PDB ID: 6W01); (B) SARS-CoV-2 spike RBD (PDB ID: 6M0J) (Spike RBD and ACE-2 surfaces shown in 
Green and rosy red color respectively); (C) SARS-CoV-2 main protease (Mpro) (PDB ID: 6WNP) (Color scheme for pocket residues: S1 red stick, S1′ blue stick, S2, green 
stick and S4 pocket cyan stick). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
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investigation, an attempt was made to evaluate the potency of some 
well-known bioflavonoids having multiple therapeutic properties 
against COVID-19, which can contribute to the scientific community 
exploring and identifying treatments for COVID-19. In the present 
investigation, molecular docking was performed on fifteen potential 
flavonoids derived from plants against three SARS- CoV-2 proteins 
namely non-structural protein-15 Endoribonuclease (NSP15), the 
receptor-binding domain of spike protein (RBD of S protein), and main 
protease (Mpro, also called 3CLpro) as targeted proteins. Further, the top 
ranking compounds on each protein were subjected to molecular dy-
namics simulation and Molecular Mechanics Poisson Boltzmann surface 
area continuum solvation (MM-PBSA) calculations to gain the deeper 
insights of binding affinity and possible mode of inhibition. 
2. Material and methods 
2.1. Molecular docking 
The molecular docking analysis of 15 bioflavonoids (Supplementary 
file) were performed on the crystal structures of NSP-15 (PDB ID: 
6W01), RBD of spike protein (PDB ID: 6M0J), and Mpro (PDB ID: 6WNP) 
with the resolutions 1.9, 2.45 and 1.44 A◦ respectively using 
Schrödinger maestro 2018-1 MM. The details of the molecular docking 
protocol are given in the supplementary file. 
2.2. Molecular dynamics (MD) simulation and molecular mechanics- 
Poisson Boltzmann surface area continuum solvation (MM-PBSA) 
calculations 
MD simulations were performed with the Gromacs 4.5.6 software 
package [29] and the ligand topologies were parameterized with the 
Gromos54a7 force field [30,31] on the ATB server [32–34]. The solvated 
and equilibrated protein-ligand complexes were subjected to 25 ns 
production phase MD simulations on the remote server of the Bioin-
formatics Resources and Applications Facility (BRAF), C-DAC, Pune. 
Further, the 25 ns trajectories were subjected to MM-PBSA calculations 
[35,36]. The details of the MD and MM-PBSA calculations are given in 
the supplementary file. 
2.3. Network pharmacology of bioflavonoids 
For the assessment of network pharmacology three major steps were 
performed: (a) prediction of bioactive targets, (b) enrichment analysis of 
regulated targets, and (c) construction of network between bioactives, 
targets, and pathways and its analysis. Briefly, targets of bio-actives 
were predicted using DIGEP-Pred [37] at the pharmacological activity 
(Pa) of 0.5 and the modulated proteins were enriched using STRING 
[38] ver 11.0 for their cellular components, biological processes, mo-
lecular function, and KEGG (https://www.genome.jp/kegg/) pathway 
database. Similarly, the network between bioactives, their targets, and 
modulated pathways was constructed using Cytoscape [39] ver 3.5.1; 
any duplicates were removed and the whole network was analyzed 
based on edge count for color map and node size. 
2.4. Prediction of probable anti-viral activity 
The biological spectrum of all the flavonoids was queried using PASS 
[40] at the pharmacological activity (Pa) > pharmacological inactivity 
(Pi) and a complete dataset was constructed. Then a complete dataset 
was queried for the keyword “viral” to identify the probable anti-viral 
activities against multiple viruses. 
3. Results and discussion 
3.1. Molecular docking studies 
The open reading frame 1 ab (ORF1ab) located at 5’ terminus of the 
SARS-CoV-2 genome encodes various non-structural proteins (NSP1-16) 
[41]. The NSP15 protein, a NendoU, is a monomer assemble into hex-
amer, generated by a dimer of trimers [42]. The crystal structure of 
NSP15 (PDB ID: 6W01) has been solved with the resolution of 1.90 Å 
and was found suitable for docking studies. Each monomer has 348 
amino acid units and constitutes a catalytic C-terminal nidoviral RNA 
uridylate-specific endoribonuclease (NendoU) domain, a middle 
domain, and an N-terminal domain. However, 23 residues are missing in 
the crystal structure in each monomeric chain and these residues were 
modeled through the Prime module. The NendoU domain has the 
endoribonuclease activity which is responsible for cutting the 
double-stranded (ds) RNA substrates. The C-terminal catalytic domain 
comprises of two antiparallel β-sheets containing six key amino acids 
His235, His250, Lys290, Thr341, Tyr343, and Ser294 (Fig. 1). The 
residues His235, His250, Lys290 form a catalytic triad where His235 
serves as an acidic residue while His250 and Lys290 serve as a basic 
residue. The residues Ser294 and Tyr343 govern the uridylate-specific 
endoribonuclease specificity. A citrate ion is bound at this site and this 
binding site is exploited in the docking studies. 
Another target protein explored in this computational study is the 
SARS-CoV-2 spike RBD. SARS-CoV-2 uses this fusion spike glycoprotein 
to make entry into the host cells through the ACE-2 receptor [43,44]. 
The spike glycoprotein has two subunits S1 and S2 which mediate 
attachment and membrane fusion respectively. The binding of the S1 
subunit to the ACE-2 receptor results in the transition of the S2 subunit 
to a highly stable post-fusion conformation [45,46]. The RBD S1 subunit 
has 5 twisted β sheets antiparallel to each other designated as β1, β2, β3, 
β4, and β7 sheets. The region between β4 and β7 strands has extended 
insertions of short β5 and β6 strands, α4 and α5 helices, and some loops. 
This extended insertion is called a receptor-binding motif (RBM) and it 
has most of the residues which bind to ACE-2 [43]. Our recent report [4] 
confirmed that the residues Lys417, Gly446, Tyr449, Tyr453, Leu455, 
Phe456, Ala475, Phe486, Asn487, Tyr489, Gln493, Gly496, Gln498, 
Thr500, Asn501, Gly502, Tyr505 are crucial for binding with N-terminal 
peptidase domain of ACE-2. However, from the cluster of these residues 
Gln493, Asn501, Tyr449, Tyr489, and Tyr505 could form the hydrogen 
bonding interaction, whereas Lys417 forms a salt bridge interaction. 
The two overlapping poly-proteins (pp1a, pp1ab) encoded by ORF 1 
ab are cleaved into NSP1-16 by the main protease (Mpro) and the papain- 
like protease (PLpro) [47–49]. Amongst these two proteases, Mpro has 
gained much attention in drug development due to its key function in 
viral replication [47]. Numerous crystal structures of SARS-CoV-2 Mpro 
are available, amongst which the crystal structure (PDB ID: 6WNP) 
having the resolution 1.44 Å was found most suitable. This crystal 
Table 1 
Molecular docking score and binding free energy for the protein-ligand com-
plexes calculated by MM-PBSA analysis, all energies are in kJ.mol− 1 with 
standard deviation in parenthesis.  
Compounds Dock Score MM-PBSA (ΔGbind) 
SARS-CoV-2 NSP-15 endoribonuclease (PDB ID: 6W01) 
Glycyrrhizic acid − 8.168 − 97.599 (±32.621) 
Baicalin − 7.564 − 47.332 (±17.273) 
Rutin − 5.575 − 52.561 (±18.521) 
Remdesivir − 5.636 − 62.637 (±20.132) 
SARS-CoV-2 spike RBD (PDB ID: 6M0J) 
Mulberroside − 7.121 − 59.846 (±21.624) 
(R)-Amygdalin − 6.978 − 14.521 (±19.927) 
Remdesivir − 4.652 − 65.198 (±19.800) 
SARS-CoV-2 main protease (Mpro) (PDB ID: 6WNP) 
Rutin − 8.859 − 129.402 (±23.245) 
Amentoflavone − 7.589 − 134.358 (±19.769) 
Remdesivir − 7.766 − 111.488 (±14.177) 
ΔGbind = Binding free energy (kJ.mol− 1), Dock Score = Glide Score. 
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structure also has a peptide inhibitor Boceprevir covalently bound to 
Cys145 residue at its binding site. The main protease forms a dimer of 
two protomers and each protomer has three domains i.e. domain I, II, 
and III comprising the residues 8–101, 102–184, and 185–306 respec-
tively. The binding site is located at the cleft between domains I and II. 
The residues Cys145 and His41 form the catalytic dyad. The binding site 
has four pockets S1, S1′, S2, and S4. The S1 pocket has the residues 
Phe140, Asn142, Glu166, His163, Leu141, and His172, while the 
adjacent S1’ pocket is surrounded by hydrophobic residues Tyr24, 
Thr25, Thr26, and Leu27. The S2 pocket is surrounded by residues 
His41, Met49, Tyr54, Met165, and Asp187, while the S4 pocket is sur-
rounded by residues Leu167, Phe185, and Gln192. 
The docking results of five top-ranked flavonoids based on the lowest 
docking scores for each protein are discussed in the case of each protein. 
The docking results for SARS-CoV-2 NSP15 Endoribonuclease are given 
in Table 1 and supplementary file- Table S1. 
The docking results on the NSP15 endoribonuclease of SARS-CoV-2 
revealed that the compounds glycyrrhizic acid, baicalin, rutin, ilexge-
nin A, hesperidin have the lower docking scores in the range − 8.168 to 
− 5.29; while the docking score for the standard drug remdesivir is 
− 5.636. The key residues at the binding site of NSP-25 belong to the C- 
terminal catalytic domain catalytic triad His235, His250, Lys290, and 
Thr341, Tyr343, and Ser294. It would be worthwhile to investigate how 
the compounds interact with the catalytic triad residues and other res-
idues. Glycyrrhizic acid was found most active with the lowest docking 
score of − 8.168 and the carboxylate anion on the sugar moiety forms a 
hydrogen bond interaction with protonated His250 residue and also 
forms a salt bridge interaction with basic Lys290 residue (Fig. 2). 
Another carboxylate anion forms a hydrogen bond with Gln245 residue, 
while the carboxylate anion on the aglycone part forms a hydrogen bond 
with Asn278. The hydrophobic pentacyclic aglycone moiety of glycyr-
rhizic acid binds at the hydrophobic pocket surrounded by hydrophobic 
residues Leu346, Tyr343, Val292 and Trp333 and some charged resi-
dues such as Lys345, Hip235, and polar residue Thr341. The Thr341 and 
Gly248 also form hydrogen bond interactions. Baicalin has the docking 
score − 7.564 and it forms the π-cation interaction between the phenyl 
ring substituted on chromone ring and positively charged Lys345 res-
idue. The salt bridge interaction is formed between the anionic 
carboxylate group on sugar moiety and protonated His235 residue. 
Other residues such as polar Thr341, positively charged Lys290, and 
hydrophobic Val292 also form hydrogen bonds with the hydroxyl 
groups. The chromone ring of rutin forms a π-π stacking as well as 
π-cation interaction with the protonated His235. The hydroxyl groups 
on the phenyl ring form hydrogen bond interaction with Glu340; while 
the hydroxyl group at the 5th position of the chromone ring forms 
hydrogen bond interaction with polar Gln245 and hydrophobic Leu246 
residues. The hydroxyl groups of sugar moiety form hydrogen bonds 
with Gly248 residue. Ilexgenin A, a hydrophobic pentacyclic triterpe-
noid core ring containing compound, has two carboxylic acid groups 
both of which are deprotonated at pH 7.4 as predicted by the Epik 
module. One of the carboxylate ions forms an ionic salt bridge interac-
tion with protonated His250 residue and hydrogen bond interaction 
with polar Thr341 and protonated His241 residues. The carbonyl oxy-
gen and a hydroxyl group at the 5th position of the chromone ring in 
hesperidin form hydrogen bonds with Lys290 and protonated His250 
residues respectively; while the hydroxyl groups on sugar moieties form 
hydrogen bonds with Glu340 and Asp240 residues. Interestingly, it was 
found that the reference drug remdesivir forms the π-π stacking inter-
action with hydrophobic Trp333 residue. The hydroxyl group on ribose 
moiety forms a hydrogen bond with negatively charged Asp240 residue. 
The phosphate oxygen atoms form hydrogen bonds with Gln245 and 
protonated His235, while the ester carbonyl group forms a hydrogen 
bond with Pro344 residue. These docking results suggest that the 
hydrogen bond interactions with the residues forming a catalytic triad 
His235, His250, Lys290 are important for the binding affinity. 
In the case of SARS-CoV-2 spike RBD, the docking scores for five top- 
ranked compounds from lower to higher values were in the order mul-
berroside < (R)-amygdalin < hesperidin < baicalin < orientin. This 
suggests the most favorable binding affinity of SARS-CoV-2 spike RBD is 
for the compound mulberroside (Supplementary file- Table S2). The 
hydroxyl groups on the sugar moieties in mulberroside form hydrogen 
bonds with negatively charged Glu484 and Glu406 residues and 
Fig. 2. Binding poses of five top-ranked compounds and remdesivir at the binding site of SARS-CoV-2 NSP15 Endoribonuclease and 2D interaction diagrams. (A) 
Glycyrrhizic Acid, (B) Baicalin, (C) Rutin, (D) Ilexgenin A, (E) Hesperidin, and (F) Remdesivir. 
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positively charged Arg403 residue (Fig. 3). The central phenyl chalcone 
core accommodates in the hydrophobic pocket surrounded by residues 
Pro491, Leu492, Gln493, Tyr495, Tyr453, and Leu455. In the case of 
(R)-amygdalin, the phenyl ring forms π-cation interaction with posi-
tively charged Arg403 residue. Arg403 also forms a hydrogen bond with 
the glycosidic linkage oxygen atom. The hydroxyl groups on sugar 
moiety form hydrogen bonds with Lys417, Gln409, Glu406, and Tyr453 
residues. The hydroxyl group on the phenyl ring in hesperidin forms a 
hydrogen bond with Gly496; while the hydroxyl groups on sugar moi-
eties form a hydrogen bond with negatively charged Glu406, Asp420, 
Fig. 3. Binding poses of five top-ranked compounds and remdesivir at the binding site of SARS-CoV-2 Spike RBD. (A) Mulberroside, (B) (R)-Amygdalin, (C) Hes-
peridin, (D) Baicalin, (E) Orientin, and (F) Remdesivir. 
Fig. 4. Binding poses of five top-ranked compounds and remdesivir at the binding site of SARS-CoV-2 Main protease (Mpro). (A) Rutin, (B) Amentoflavone, (C) 
Myricetin, (D) Baicalein, (E) Hesperidin, (F) Remdesivir. 
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and positively charged Lys417. In the case of baicalin the phenyl ring 
substituted on chromone ring forms π- π stacking interaction with 
Tyr505; while the hydroxyl group on sugar moiety forms a hydrogen 
bond with Gln409 and negatively charged Glu406 residue. The depro-
tonated anionic carboxylate forms a salt bridge with positively charged 
Arg403 residue. Only hydroxyl groups on sugar moieties in the case of 
Orientin forms hydrogen bond interaction with Asn501, Gly496, 
Ser494, Gln493 residues. 
The phenyl ring in remdesivir also forms π- π stacking interaction 
with Ser494 residue, while the hydroxyl groups on ribose form hydrogen 
bonds with negatively charged Glu406 residue. The nitrogen from the 
cyano group forms a hydrogen bond with positively charged Arg403 
residue, while the nitrogen atom from the phosphamidon group forms a 
hydrogen bond with Gln493 residue. Most of these interactions were 
with the residue clusters from the interface of spike RBD and ACE-2 as 
mentioned earlier. Many of the favorable interactions were found with 
some important residues such as Gln493, Asn501, Tyr449, Tyr489, 
Tyr505, and Lys417. 
The docking results for SARS-CoV-2 main protease (Mpro) showed 
that rutin has the best docking score (− 8.859) amongst all flavonoids 
Fig. 5. Root Mean Square Deviations. RMSD in protein backbone atoms of - (A) NSP-15 endoribonuclease; (B) Spike RBD; and (C) Main protease (Mpro). RMSD in 
ligand atoms - (D) NSP-15 endoribonuclease; (E) Spike RBD; and (F) Main protease (Mpro) (MAL: Mulberroside, AMY: (R)-Amygdalin, REM: Remdesivir, RUT: Rutin, 
AMA: Amentoflavone). 
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(Supplementary file- Table S3). Other flavonoids namely amento-
flavone, myricetin, baicalein, hesperidin have the docking scores in the 
range − 7.589 to − 7.137. The reference drug remdesivir has a docking 
score of − 7.766 which points out the stronger binding affinity of rutin 
than the reference drug. The binding pose of best docked rutin 
conformer was found to form the hydrogen bond with two residues 
deprotonated Glu166 and polar Asn142 at S1 pocket, while at S1′ pocket 
it forms hydrogen bond interaction with Thr26 (Fig. 4). The 3,4 dihy-
droxyl groups on phenyl substituent form these hydrogen bonds at both 
S1 and S1′ pockets with Asn142 and Thr26 residue. The hydroxyl groups 
on α-L-rhamnopyranose moiety form hydrogen bonds with polar Ser46 
residue at S2 pocket and polar Gln189 residue at S4 pocket. Thus, rutin 
was found to occupy the binding site and forming important hydrogen 
bond interactions at all the pockets of SARS-CoV-2 main protease (Mpro). 
Remdesivir, on the other hand also occupies all the pockets, but it forms 
hydrogen bond interactions with S1 pocket residue Glu166 and S1′
pocket residue Thr26. The phenyl ring substituted on phosphoramide 
forms a π- π stacking interaction with S2 pocket protonated residue 
His41. Amentoflavone forms hydrogen bond interactions with S1 pocket 
residue Glu166, S1′ pocket residue Thr25, S2 pockets residues His41, 
and Ser46. It also forms a π- π stacking interaction with protonated His41 
residue. Myricetin forms the hydrogen bond with Glu166 and Leu141 
residues at S1 pocket and Arg188 residue at S2 pocket. Baicalein, with 
hydroxyl groups on the core chromone ring, form hydrogen bond 
interaction with S1 and S1’ pocket residues Asn142, Gly143, and Thr26. 
Hesperidin, a close analog of rutin, forms a hydrogen bond with S1 
pocket residues Asn142, Leu141, and Glu166. These results suggest that 
the flavonoid rutin has a better binding affinity due to interactions with 
key residues at all the pockets of the binding site of SARS-CoV-2 main 
protease (Mpro). 
3.2. Molecular dynamics studies and MM-PBSA calculations 
Molecular dynamics simulation (MDS) is known to provide binding 
mode of ligand accurately than the molecular docking. MDS of suffi-
ciently long duration offers the conformational sampling of ligand as 
well as protein backbone and side-chain atoms. On the other hand, it 
also provides the essential information in terms of the various non- 
bonded interactions and consequent energetic of solvated system. 
Further, it captures the protein folding events, the influence of loop 
flexibility, and biding site adaptation. This eliminates the limitations of 
docking studies and provides accurate estimates of the binding free 
energy and binding affinity. In the present study, 25 ns MDS studies 
were performed to evaluate the conformational stability, binding free 
energy, and binding affinity of the compounds with the best docking 
scores, and the results were compared with reference drug remdesivir. In 
the case of SARS-CoV-2 NSP-15 endoribonuclease, the top-ranked fla-
vonoids glycyrrhizic acid, baicalin, rutin were selected for MDS; while 
with the SARS-CoV-2 spike, RBD the flavonoids mulberroside and (R)- 
amygdalin were selected. In the case of SARS-CoV-2 main protease, the 
flavonoids rutin and amentoflavone were selected. The MDS of the 
reference drug remdesivir was also performed. During the MDS stearic 
clashes were relieved by subjecting the system to the initial steps of 
energy minimization by steepest descent criteria. The minimized system 
was subjected to equilibration steps at NPT and NVT conditions. The 
equilibrated system was subjected to 25 ns production phase MDS and 
the post MDS analysis which includes analysis of various non-bonded 
interactions such as H-bond, π stacking and hydrophobic interactions. 
In order to understand the stability of the system during the MDS 
timescale, the parameters such as root mean square deviation (RMSD) 
and root mean square fluctuation (RMSF) for ligands as well as protein 
were measured. The post MDS trajectories were used in Molecular Me-
chanics Poisson-Boltzmann Surface Area (MM-PBSA) calculations to 
estimate the binding free energies. 
The RMSD is a good measure of conformational stability of protein 
and ligands and its a measure of extent of deviation in the position of 
atoms from the starting position. The lower the deviation better is the 
conformational stability [50]. The RMSD analysis for protein atoms 
showed that the complex of SARS-CoV-2 NSP-15 endoribonuclease with 
remdesivir has the lowest RMSD with an average of 0.24 nm (Fig. 5). The 
complex with glycyrrhizic acid has almost equal RMSD as that of 
remdesivir till 15 ns, but thereafter it increases and the average RMSD is 
0.29 nm. The complex of baicalin stabilizes quickly with an average 
RMSD of 0.299 nm. The complex of rutin has the highest deviations with 
an average RMSD of 0.39 nm. It was found that though the remdesivir 
Fig. 6. RMSF in residues of proteins. (A) Complexes with SARS-CoV-2 NSP-15 
endoribonuclease; (B) complexes with SARS-CoV-2 spike RBD (MAL: Mulber-
roside, AMY: (R)-Amygdalin, and REM: Remdesivir); and (C) Complexes with 
SARS-CoV-2 main protease (Mpro) (RUT: Rutin, AMA: Amentoflavone). 
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docking score is higher, its complex is stabilized quickly as compared to 
other complexes, and glycyrrhizic acid and baicalin has almost similar 
deviations in protein atoms. In the case of SARS-CoV-2 spike RBD, 
mulberroside and (R)-amygdalin has the best docking scores. The RMSD 
in protein atoms for these two compounds and the reference drug 
remdesivir showed that the mulberroside and remdesivir have almost 
similar deviations in protein atoms with average values of 0.26 and 0.23 
respectively suggesting better stabilization in both the cases [51]. While 
the RMSD for a complex of (R)-amygdalin is having a slightly higher 
average of 0.33 suggesting lower stability as compared to the other two 
complexes. In the case of SARS-CoV-2 main protease, the compounds i.e. 
rutin and amentoflavone, showed better docking scores, and remdesivir 
has very close RMSD values of 0.25, 0.26, and 0.22 respectively. 
Moreover, these results are supporting the docking scores. 
The measurement of RMSD in ligand atoms is also important in 
judging the overall stability of the protein-ligand complexes. In the case 
Fig. 7. Number of hydrogen bonds formed between the molecules and the residues at the binding site. SARS-CoV-2 NSP-15 endoribonuclease (A) Glycyrrhizic acid, 
(B) Baicalin, (C) Rutin, (D) Remdesivir; SARS-CoV-2 Spike RBD (E) Mulberroside, (F) (R)-Amygdalin, (G) Remdesivir; SARS-CoV-2 Main protease (Mpro). (H) Rutin, 
(I) Amentoflavone, (J) Remdesivir. 
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of the complexes of SARS-CoV-2 NSP-15 endoribonuclease with ligands, 
baicalin atoms have the least deviations with an average RMSD value of 
0.14 nm, while the remdesivir atoms have the higher deviations with an 
average RMSD of 0.30 nm (Fig. 5D). The flavonoids glycyrrhizic acid 
and rutin have an average RMSD of 0.24 and 0.22 nm respectively. It 
was found that the RMSD is proportional to the number of rotatable 
bonds in the molecules. For instance, baicalin with 4 rotatable bonds has 
the lowest RMSD value, while the remdesivir with 14 rotatable bonds 
has the highest RMSD value. For glycyrrhizic acid and rutin with 7 and 6 
rotatable bonds respectively, the RMSD values vary proportionally. In 
the case of the complexes of SARS-CoV-2 spike RBD with ligands, all the 
ligands were found adopting stable conformation with RMSD of around 
0.25 nm at the end of 25 ns MDS. Interestingly, in the case of mulber-
roside, till around 17.5 ns the RMSD is almost stable with a lower RMSD 
value of around 0.15 nm, but thereafter it quickly raises to around 0.25 
nm and remains stable till the end of the simulation. In the case of the 
complexes of SARS-CoV-2 main protease (Mpro), it can be seen that the 
flavonoid amentoflavone has the least deviations from the starting 
structure with an average RMSD of 0.13 nm, suggesting the stability of 
its complex with the main protease. While, the reference drug remde-
sivir has a higher but constant deviation with RMSD of around 0.25 nm 
till 20 ns, but thereafter it rises to around 0.35 nm towards the end of the 
simulation. This suggests larger deviations in the starting structure of 
remdesivir. Interestingly, rutin also has a higher initial RMSD of around 
0.25 nm, but the RMSD drops to a stable conformation with RMSD 
around 0.2 nm soon after 20 ns simulation. 
The stability of protein-ligand complexes can be evaluated in terms 
of Root Mean Square Fluctuations (RMSF) in the atoms of protein resi-
dues [52]. It is a good measure of elasticity of the protein residues and 
points out the binding site adaptation and other phenomena. In the case 
of the SARS-CoV-2 NSP-15 endoribonuclease, the fluctuations in a 
cluster of residues were evident with rutin and baicalin; while these 
were minimal with glycyrrhizic acid and remdesivir (Fig. 6). 
Maximum fluctuations were seen amongst the cluster of N-terminal 
residues ranging from 1 to 50 and to some extent minor fluctuations 
were seen in the binding site residues in the range 225–346. In the SARS- 
CoV-2 spike RBD-ligand complexes, the cluster of residues from 350 to 
375 from the N-terminal region and binding site residues from 375 to 
500 had higher fluctuations. The fluctuations in the N-terminal residues 
were minimal as observed with remdesivir and maximal with (R)- 
amygdalin, while the fluctuations at the binding site residues were 
almost similar to all the compounds. In the case of the complexes of 
SARS-CoV-2 main protease (Mpro), the fluctuations in the binding site 
residues 25–50, 150–200, and C-terminal loop region residues 275–306 
were observed with all the three compounds. 
The binding affinity of ligands depends on the non bonded in-
teractions such as hydrogen bond interactions, hydrophobic and ionic 
interactions [53]. The number of hydrogen bonds formed, and their 
lifetime indicates the strength and binding affinity of the complexes. The 
hydrogen bond formation was critically evaluated for all protein-ligand 
complexes. In the case of SARS-CoV-2 NSP-15 endoribonuclease, the 
maximum 10 hydrogen bonds were formed with glycyrrhizic acid, while 
with rutin 7 hydrogen bonds were formed (Fig. 7). In the case of baicalin 
and remdesivir, 5 hydrogen bonds were formed. The estimate of the 
average number of hydrogen bonds formed during the entire simulation 
period may be crucial in judging which molecule is constantly forming 
more number of hydrogen bonds [54]. Glycyrrhizic acid, rutin, baicalin, 
and remdesivir form an average of 4.45, 2.41, 1.57, and 1.85 number of 
hydrogen bonds respectively. Thus, glycyrrhizic acid is forming 
approximately 4 hydrogen bonds constantly throughout the MDS, while 
other compounds form approximately 1–2 hydrogen bonds constantly. 
Further, the residues involved in hydrogen bond formation and the 
lifetime of hydrogen bonds were studied. In this case, a program 
PyContact [55], a GUI-based tool for analysis of non-covalent in-
teractions was used. The hydrogen bond formation was analyzed with a 
cut off the radius of 0.35 nm and an angle cut off of 120◦ criteria [56]. In 
the case of glycyrrhizic acid, the residues Val292 and Tyr343 form the 
hydrogen bonds with the longest lifetime, while in the case of baicalin 
the residue Lys290 forms a hydrogen bond with the longest lifetime 
(Supplementary file S4- Figure S2). The flavonoid rutin forms the 
hydrogen bonds with the residues Gln245, Lys290, and Tyr343 with the 
longest lifetime. 
The reference drug remdesivir forms hydrogen bonds with residues 
Gly248, His235, Lys290, Gln245, Tyr243, His250, and Gly247 with the 
longest lifetime. These results suggest that remdesivir could produce 
hydrogen bonds with many key residues at the binding site. It was also 
observed that the residues Lys290, Tyr343, and Gln245 are important in 
hydrogen bond formation. 
In the case of SARS-CoV-2 spike RBD, the maximum 8 hydrogen 
bonds were formed with remdesivir; while mulberroside and (R)- 
amygdalin forms 7 hydrogen bonds each. However, the average number 
of hydrogen bonds formed with remdesivir, mulberroside, and (R)- 
amygdalin were 3.52, 3.81, and 3.70 respectively, which suggest that 
hydrogen bond formation events happen more frequently with mul-
berroside. The analysis of residue wise hydrogen bond lifetime suggests 
that the Tyr120, Leu122, Tyr156, Tyr162, and Arg70 residues form 
hydrogen bonds consistently with longer lifetime (Supplementary file- 
Figure S3). (R)-Amygdalin residues Arg70 and Glu73 form such 
hydrogen bonds with longer lifetime. Interestingly, remdesivir forms 
several such hydrogen bonds with residues Glu160, Tyr120, Tyr162, 
Ser161, Arg70, and Gly163. These results point to the importance of 
Tyr120, Tyr162, and Arg70 residues in these compounds. Depending on 
the consistency of hydrogen bonds formed, remdesivir may have a 
stronger binding affinity than mulberroside. 
In the case of the complexes of SARS-CoV-2 main protease (Mpro), 
rutin, amentoflavone, and remdesivir form 12, 7, and 9 maximum 
number of hydrogen bonds respectively. The average number of 
hydrogen bonds formed during the period of simulation for rutin, 
amentoflavone, and remdesivir was 5.95, 2.05, and 4.75 respectively. 
Thus, it is evident that rutin forming a greater number of hydrogen 
bonds consistently compared to amentoflavone and remdesivir. Rutin 
may have a more favorable binding affinity due to such hydrogen bond 
formation than the other two compounds. The hydrogen bond formation 
pattern at the binding site in terms of hydrogen bond lifetime was 
investigated which suggests that rutin could form hydrogen bonds with 
the number of residues at the binding site of SARS-CoV-2 main protease 
(Mpro) (Supplementary file- Figure S4). Interestingly, the residues from 
all the four pockets were found involved in such key hydrogen forma-
tion. Especially, the S1 pocket residues Glu166, Gly143 and Cys145, S1’ 
pocket residues Leu27, Thr26, Thr25, S2 pocket residues Cys44, His41, 
Met165, and Met49 and S4 pocket residue Gln189 were found forming 
hydrogen bonds consistently. In the case of amentoflavone, these resi-
dues and S1 pocket residue His163 were found involved in hydrogen 
bond formation. Remdesivir forms hydrogen bonds with most of these 
residues and Thr190, His164, and Pro168 residues. These results suggest 
that the residues Glu166, His41, Gln189 are important in forming key 
hydrogen bond interactions. 
MM-PBSA calculations carried out MD trajectories can provide more 
accurate estimates of binding affinity in terms of binding free energy. 
The g_mmpbsa program [35,36] is useful in calculating the non-bonded 
interaction energies such as van der Waal energy, electrostatic energy, 
polar solvation energy, Solvent Accessible Surface Area (SASA) energy, 
and these energy values are used to calculate the binding free energy 
(ΔGbinding) (Supplementary file- Table S4). The non-bonded interaction 
energies such as van der Waal energy and electrostatic energy in terms of 
Coulomb and Lennard-Jones (LJ) potential functions respectively, has a 
major influence on the binding free energy (ΔGbinding) estimate. In the 
case of MDS of SARS-CoV-2 NSP-15 endoribonuclease protein-ligand 
complexes, the MM-PBSA results showed that glycyrrhizic acid has the 
lowest van der Waal energy and has the lowest binding free energy of 
− 97.599 kJ/mol. In comparison to the reference drug remdesivir, the 
binding free energy of glycyrrhizic acid is much lower. This may be in 
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part due to the higher number of hydrogen bonds formed and conse-
quently most favorable interactions at the binding site. This proves that 
the glycyrrhizic acid, amongst all the flavonoids, interacts most favor-
ably interacts at the binding site of SARS-CoV-2 NSP-15 endor-
ibonuclease. Baicalin and rutin having comparably lower ΔGbinding may 
have less favorable interactions than the reference drug. The in-
teractions formed by glycyrrhizic acid and remdesivir when compared, 
it was found that glycyrrhizic acid forms polar interactions with the 
residues Asn278, Ser294, Cys293, Glu340, Leu246, Leu346, Lys346, 
Lys345, His243, and Trp333; while the reference drug remdesivir was 
observed not forming interactions with these residues (Supplementary 
file- Figure S5). 
In the case of MDS of SARS-CoV-2 Spike protein-ligand complexes, 
the results of MM-PBSA calculations showed that remdesivir has the 
lowest binding free energy as compared to the other two flavonoids. 
However, mulberroside was found to have better van der Waals in-
teractions than remdesivir. But the results are not so conclusive in 
deciding the better binding affinities of flavonoids to this target protein. 
In the case of MDS of SARS-CoV-2 Main protease (Mpro) protein- 
ligand complexes, Amentoflavone was found to have better lower 
binding free energy than the remdesivir. But only polar solvation energy 
contributions differ considerably in the final binding free energies. 
3.3. Network pharmacology 
3.3.1. Targets of bio-actives 
A total of 199 proteins were modulated by 15 flavonoids in which 
myricetin and scutellarein were major protein regulators i.e. 28 
(Table 2). Similarly, PLAU and TIMP1 proteins were most regulated 
proteins by the maximum number of bio-actives i.e. 11 (Table 3). 
3.3.2. GO enrichment and network analysis 
Gene ontology analysis identified 565 biological processes in which 
response to hypoxia (GO:0001666) scored the lowest false discovery 
rate via the modulation of 13 genes (CAT, CYP1A1, EGLN1, EPAS1, 
HMOX1, MDM2, MMP2, NFE2L2, NOS2, PLAT, PLAU, PPARA, SIRT1) 
against 288 background proteins. Similarly, 69 molecular functions 
were identified in which protein binding (GO:0005515) was majorly 
modulated with the lowest false discovery rate via the modulation of 34 
genes (AR, CASP8, CAT, CHEK1, CTNNB1, CYP1A1, CYP1A2, EGLN1, 
EPAS1, ESR2, FKBP5, FLT1, GSS, GYPA, HMOX1, KRT1, MDM2, 
NFE2L2, NOS2, NPPB, PGR, PLAT, PPARA, PRDX4, PRKCA, SIRT1, 
SMN2, TIMP1, TNFRSF1A, TOP2A, TP53I3, TP63, TP73, VDR) against 
6605 background proteins. Likewise, 14 cellular components were 
majorly modulated in which extracellular space (GO:0005615) scored 
minimum false discovery rate via the modulation of 12 genes (CD86, 
FLT1, HMOX1, KLK3, MMP2, MMP3, MMP7, NPPB, PLAT, PLAU, 
TIMP1, TNFRSF1A) against 1134 background proteins (Fig. 8). Simi-
larly, KEGG analysis identified the modulation of 63 pathways in which 
pathways in cancer (hsa05200) was primarily modulated by regulating 
14 proteins (AR, CASP8, CTNNB1, EGLN1, EPAS1, ESR2, GADD45B, 
HMOX1, KLK3, MDM2, MMP2, NFE2L2, NOS2, PRKCA) against 515 
background proteins with the lowest false discovery rate (Supplemen-
tary file- Table S5). Similarly, the network interaction of bio-actives, 
modulated proteins, and regulated pathways reflected the myricetin 
and scutellarein with the highest number of proteins in which CTNNB1 
was primarily modulated in a maximum of pathways chiefly modulating 
pathways in cancer (Fig. 9). 
3.3.3. Prediction of probable anti-viral activity 
Prediction of the biological spectrum of bio-actives identified 16 
different anti-viral activities for the keyword “viral” as anti-adenovirus, 
CMV, hepatitis B and C, hepatitis, herpes, HIV, influenza, picornavirus, 
poxvirus, rhinovirus, trachoma, viral entry inhibitor in which the com-
bined action was integrated against ‘antiviral’ (Influenza). The antiviral 
activity of the combined action of selected flavonoids is presented in 
Fig. 10. 
Apart from the anti-viral spectrum of the selected bio-actives against 
the novel coronavirus, the study also aimed to investigate the probable 
regulation of multiple proteins via the compounds. This is because, 
during COVID-19 infection, it has been proposed for the deregulation of 
nutrient and oxygen supply in the affected tissue leading to necrosis 
which could be the basic pathogenesis observed in autopsy [57]. This 
process is complex and involved the up-/down-regulation of multiple 
proteins and regulation of numerous pathways by affecting various 
cellular components, molecular functioning, and biological process 
which can be traced via the assessment of gene ontology enrichment 
analysis. Similarly, the present study enriched the bio-actives regulated 
proteins to evaluate their synergistic or additive probability for multiple 
pathways in regulating immunity, inflammation, and oxidative stress. 
The risk of COVID-19 infection is reported to be more in subjects 
with co-morbid multiple infectious diseases (tuberculosis, malaria, HIV, 
etc) and non-infectious diseases (diabetes, obesity, cancer, etc) due to 
compromised immunity [58,59]. Similarly, inflammation in the lungs 
and increased oxidative stress are also contributors to the progression of 
Table 2 
Bioactives and their count to regulated targets.  
Bioactives Count of targeted 
proteins 
Bioactives Count of targeted 
proteins 
(R)-Amygdalin 8 Lycorine 1 
Amentoflavone 24 Mulberroside 15 
Baicalein 22 Myricetin 28 
Baicalin 4 Orientin 13 
Glycyrrhizic 
Acid 
5 Puerarin 8 
Hesperetin 19 Rutin 13 
Hesperidin 9 Scutellarein 28 
Ilexgenin A 2  
Total (Count of targeted proteins): 199  
Table 3 
Targets and their count to regulators.  
Proteins Count of Bioactives Proteins Count of Bioactives Proteins Count of Bioactives Proteins Count of Bioactives 
AR 9 EPAS1 4 MMP2 5 PRDX4 5 
CASP8 4 ESR2 1 MMP3 3 PRKCA 1 
CAT 6 FKBP5 1 MMP7 7 SIRT1 4 
CBR1 1 FLT1 2 NFE2L2 6 SMN2 10 
CD83 3 GADD45B 1 NOS2 7 TIMP1 11 
CD86 1 GSS 1 NPPB 5 TNFRSF1A 8 
CHEK1 6 GYPA 1 PGR 5 TOP2A 1 
CTNNB1 7 HMOX1 9 PLAT 9 TP53I3 2 
CYP1A1 4 KLK3 5 PLAU 11 TP63 1 
CYP1A2 1 KRT1 6 PPARA 2 TP73 5 
EGLN1 2 MDM2 5 PRDX2 4 VDR 7 
Total: 199  
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COVID-19 pathogenesis [60]. The selected bio-actives are the flavo-
noids, an important class of secondary metabolites with multiple bene-
ficial values including immune booster, anti-inflammatory, and 
antioxidant activities. Hence, the present study utilized the GO analysis 
followed by network interaction of flavonoids to evaluate the above 
triplex action, which would be beneficial in the subjects with compro-
mised immunity. 
GO analysis identified the modulation of 565 biological processes in 
which response to hypoxia was majorly modulated. As explained pre-
viously, in COVID-19 infection, hypoxia in one of the major problems 
due to inadequate O2/CO2 exchanges [61]. Hence, regulation of this 
pathway could be beneficial in ameliorating the exchange of gas and 
nutritional supply in infected cells/tissue and could synergist other 
biological processes like a response to stress and stimulus and minimize 
reactive oxygen species (ROS) system and inflammation. During drug 
action, efficacy may be affected via the change in effective concentration 
at the site of action or via the alteration of the rate of drug elimination 
[62]. Similarly, in the present study, the combined synergistic/additive 
also regulated the protein binding which would contribute to the 
regulation of pharmacokinetic/pharmacodynamic parameters. The 
Fig. 8. GO Analysis of flavonoid regulated genes.  
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previous report also reports the role of extracellular vesicles in viral 
infection and transmission [63]. In the present study, proteins from 
extracellular vesicles were predicted to be most affected which could get 
activated in response to novel coronavirus infection. Similarly, the 
present KEGG analysis identified the modulation of multiple signaling 
pathways like p53, FoxO, MAPK, Wnt, Rap1, TNF, Adipocytokine, and 
Leukocyte transendothelial migration that are involved in immune 
boost, minimizing the oxidative stress and inflammation [64–71]. 
Further, the selected bio-actives were also identified to modulate the 
multiple pathways which are involved in the multiple infectious and 
non-infectious pathogenesis and would add a beneficial effect in treating 
the subjects suffering from the same. 
4. Conclusion 
Bioflavonoids or polyphenolics are well known secondary 
metabolites possessing diverse activities including antiviral activity. In 
the present work, the possible antiviral properties of 15 bioflavonoids 
were investigated through in-silico approaches against SARS-CoV-2- 
proteins i.e. NSP15, RBD of S protein, and Mpro/3CLpro. The docking 
studies and MDS confirmed the promising potential of glycyrrhizic acid, 
baicalin, and rutin in inhibiting the n-CoV-2 key viral proteins. The 
network pharmacology analysis suggested the contribution of selected 
bioflavonoids in the modulation of multiple signaling pathways that 
could play a significant role in immunomodulation, minimizing the 
oxidative stress and inflammation. This computational assessment of 
bioflavonoids and network pharmacology work can lead researchers to 
take up and plan further experimental work on investigation of the in-
hibition of SARS-CoV-2 vital proteins with the potential secondary 
metabolite found in this study. 
Fig. 9. Network interaction of flavonoids, their targets, and regulated pathways.  
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